Literature DB >> 22528503

Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.

Elodie L Plan1, Alan Maloney, France Mentré, Mats O Karlsson, Julie Bertrand.   

Abstract

Estimation methods for nonlinear mixed-effects modelling have considerably improved over the last decades. Nowadays, several algorithms implemented in different software are used. The present study aimed at comparing their performance for dose-response models. Eight scenarios were considered using a sigmoid E(max) model, with varying sigmoidicity and residual error models. One hundred simulated datasets for each scenario were generated. One hundred individuals with observations at four doses constituted the rich design and at two doses, the sparse design. Nine parametric approaches for maximum likelihood estimation were studied: first-order conditional estimation (FOCE) in NONMEM and R, LAPLACE in NONMEM and SAS, adaptive Gaussian quadrature (AGQ) in SAS, and stochastic approximation expectation maximization (SAEM) in NONMEM and MONOLIX (both SAEM approaches with default and modified settings). All approaches started first from initial estimates set to the true values and second, using altered values. Results were examined through relative root mean squared error (RRMSE) of the estimates. With true initial conditions, full completion rate was obtained with all approaches except FOCE in R. Runtimes were shortest with FOCE and LAPLACE and longest with AGQ. Under the rich design, all approaches performed well except FOCE in R. When starting from altered initial conditions, AGQ, and then FOCE in NONMEM, LAPLACE in SAS, and SAEM in NONMEM and MONOLIX with tuned settings, consistently displayed lower RRMSE than the other approaches. For standard dose-response models analyzed through mixed-effects models, differences were identified in the performance of estimation methods available in current software, giving material to modellers to identify suitable approaches based on an accuracy-versus-runtime trade-off.

Mesh:

Year:  2012        PMID: 22528503      PMCID: PMC3385815          DOI: 10.1208/s12248-012-9349-2

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  24 in total

1.  Nonlinear mixed effects models for repeated measures data.

Authors:  M L Lindstrom; D M Bates
Journal:  Biometrics       Date:  1990-09       Impact factor: 2.571

2.  Estimating bias in population parameters for some models for repeated measures ordinal data using NONMEM and NLMIXED.

Authors:  Siv Jönsson; Maria C Kjellsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

Review 3.  Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.

Authors:  Goonaseelan Colin Pillai; France Mentré; Jean-Louis Steimer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-11-07       Impact factor: 2.745

4.  Analysis of population pharmacokinetic data using NONMEM and WinBUGS.

Authors:  Stephen B Duffull; Carl M J Kirkpatrick; Bruce Green; Nicholas H G Holford
Journal:  J Biopharm Stat       Date:  2005       Impact factor: 1.051

5.  PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Authors:  Lars Lindbom; Pontus Pihlgren; E Niclas Jonsson; Niclas Jonsson
Journal:  Comput Methods Programs Biomed       Date:  2005-09       Impact factor: 5.428

6.  Comparison of population pharmacokinetic modeling methods using simulated data: results from the Population Modeling Workgroup.

Authors:  D J Roe
Journal:  Stat Med       Date:  1997-06-15       Impact factor: 2.373

7.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

8.  Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

9.  Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model.

Authors:  J L Steimer; A Mallet; J L Golmard; J F Boisvieux
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

10.  Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1980-12
View more
  15 in total

1.  Novel hybrid GPU-CPU implementation of parallelized Monte Carlo parametric expectation maximization estimation method for population pharmacokinetic data analysis.

Authors:  C M Ng
Journal:  AAPS J       Date:  2013-09-04       Impact factor: 4.009

2.  Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM.

Authors:  François Riglet; France Mentre; Christine Veyrat-Follet; Julie Bertrand
Journal:  AAPS J       Date:  2020-02-19       Impact factor: 4.009

3.  Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM® Across Rich, Medium, and Sparse Sampling Data.

Authors:  Waroonrat Sukarnjanaset; Thitima Wattanavijitkul; Sutep Jarurattanasirikul
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

4.  Changing face of vaccination in immunocompromised hosts.

Authors:  Daire O'Shea; Lukas A Widmer; Jörg Stelling; Adrian Egli
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

5.  Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.

Authors:  Åsa M Johansson; Sebastian Ueckert; Elodie L Plan; Andrew C Hooker; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-05-07       Impact factor: 2.745

6.  Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.

Authors:  Xiaoxi Liu; Yuhuan Wang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-05-23       Impact factor: 2.745

7.  Predicting Antibiotic Effect of Vancomycin Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation: Dense Sampling versus Sparse Sampling.

Authors:  Yong Kyun Kim; Jae Ha Lee; Hang-Jea Jang; Dae Young Zang; Dong-Hwan Lee
Journal:  Antibiotics (Basel)       Date:  2022-05-31

8.  Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients.

Authors:  Solène Desmée; France Mentré; Christine Veyrat-Follet; Bernard Sébastien; Jérémie Guedj
Journal:  Biometrics       Date:  2016-05-05       Impact factor: 2.571

9.  Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.

Authors:  Thanh Bach; Guohua An
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-04-21       Impact factor: 2.745

10.  Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats.

Authors:  Jacob Leander; Joachim Almquist; Christine Ahlström; Johan Gabrielsson; Mats Jirstrand
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.